Steven D. Leach

Active 1988–2024

81
Papers
27,819
Citations
72
h-index
80
i10-index

Citations

Citations per year for Steven D. Leach1939: 1 citations1985: 1 citations1989: 1 citations1990: 1 citations1991: 1 citations1992: 2 citations1993: 2 citations1994: 3 citations1995: 6 citations1996: 4 citations1997: 7 citations1998: 14 citations1999: 29 citations2000: 48 citations2001: 58 citations2002: 70 citations2003: 76 citations2004: 87 citations2005: 131 citations2006: 134 citations2007: 144 citations2008: 156 citations2009: 281 citations2010: 293 citations2011: 324 citations2012: 268 citations2013: 314 citations2014: 337 citations2015: 377 citations2016: 387 citations2017: 391 citations2018: 369 citations2019: 1,012 citations2020: 1,142 citations2021: 1,175 citations2022: 853 citations2023: 686 citations2024: 831 citations2025: 420 citations2026: 15 citations1940–1984: no citations, so these years are not shown1986–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,502 citing papers, 33.5% of this breakdownChina: 1,584 citing papers, 11.8% of this breakdownGermany: 927 citing papers, 6.9% of this breakdownUnited Kingdom: 800 citing papers, 6% of this breakdownJapan: 537 citing papers, 4% of this breakdownItaly: 500 citing papers, 3.7% of this breakdownCanada: 435 citing papers, 3.2% of this breakdownFrance: 409 citing papers, 3% of this breakdownSpain: 343 citing papers, 2.6% of this breakdownNetherlands: 342 citing papers, 2.5% of this breakdownAustralia: 321 citing papers, 2.4% of this breakdownSwitzerland: 263 citing papers, 2% of this breakdown
0%33.5%Other 18.4%

Fields

  • Medicine50.6%
  • Biochemistry, Genetics and Molecular Biology36.1%
  • Immunology and Microbiology5.5%
  • Chemistry2.4%
  • Engineering2%
  • Neuroscience1.4%
  • Other2%

Topics

  • Pancreatic and Hepatic Oncology Research9%
  • Cancer Cells and Metastasis5.3%
  • Cancer Genomics and Diagnostics4.5%
  • Cancer Immunotherapy and Biomarkers2.7%
  • Epigenetics and DNA Methylation2.7%
  • Pancreatic function and diabetes2.3%
  • Other73.5%

Coauthors

All papers

Open in search
  1. Organoid Models of Human and Mouse Ductal Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Folkert H.M. Morsink, I. Quintus Molenaar, Inne H. Borel Rinkes, Edwin Cuppen, Hao Yuan, Ying Jin, Isaäc J. Nijman, Christine A. Iacobuzio–Donahue, Steven D. Leach, Darryl Pappin, Molly Hammell, David S. Klimstra, Olca Baştürk, Ralph H. Hruban, G. Johan A. Offerhaus, Robert G. Vries, Hans Clevers, David A. Tuveson - Cell 2014 cited by 2,196

  2. EMT and Dissemination Precede Pancreatic Tumor Formation

    Authors: , , , , , , , , , , , - Cell 2012 cited by 2,138

  3. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sacha Gnjatic, Christine A. Iacobuzio–Donahue, Jedd D. Wolchok, Ronald P. DeMatteo, Timothy A. Chan, Benjamin D. Greenbaum, Taha Merghoub, Steven D. Leach - Nature 2017 cited by 1,229

  4. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Karchin, Nickolas Papadopoulos, Giovanni Parmigiani, Bert Vogelstein, Victor E. Velculescu, Kenneth W. Kinzler - Science 2008 cited by 4,055

  5. A draft map of the human proteome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandip Chavan, Keshava K. Datta, Yashwanth Subbannayya, Apeksha Sahu, Soujanya D. Yelamanchi, Savita Jayaram, Pavithra Rajagopalan, Jyoti Sharma, Krishna R. Murthy, Nazia Syed, Renu Goel, Aafaque Ahmad Khan, Sartaj Ahmad, Gourav Dey, Keshav Mudgal, Aditi Chatterjee, Tai‐Chung Huang, Jun Zhong, Xinyan Wu, Patrick G. Shaw, Donald Freed, Muhammad Saddiq Zahari, Kanchan K. Mukherjee, Subramanian Shankar, Anita Mahadevan, Henry Lam, Chris J. Mitchell, Susarla Krishna Shankar, Parthasarathy Satishchandra, John T. Schroeder, Ravi Sirdeshmukh, Anirban Maitra, Steven D. Leach, Charles G. Drake, Marc K. Halushka, Thottethodi Subrahmanya Keshava Prasad, Ralph H. Hruban, Candace L. Kerr, Gary D. Bader, Christine A. Iacobuzio–Donahue, Harsha Gowda, Akhilesh Pandey - Nature 2014 cited by 2,311

  6. A gene–environment-induced epigenetic program initiates tumorigenesis

    Authors: , , , , , , , , , , , , , , , , , , , - Nature 2021 cited by 321

  7. ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2020 cited by 341

  8. α-Ketoglutarate links p53 to cell fate during tumour suppression

    Authors: , , , , , , , , , , , , , - Nature 2019 cited by 299

  9. Oncogenic Kras Activates a Hematopoietic-to-Epithelial IL-17 Signaling Axis in Preinvasive Pancreatic Neoplasia

    Authors: , , , , , , , , , , , , , , , , , - Cancer Cell 2014 cited by 405

  10. Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth H. Yu, Dean F. Bajorin, Jonathan Coleman, Steven D. Leach, Maeve A. Lowery, Julio García‐Aguilar, Philip W. Kantoff, Charles L. Sawyers, Maura N. Dickler, Leonard B. Saltz, Robert J. Motzer, Eileen M. O’Reilly, Howard I. Scher, José Baselga, David S. Klimstra, David B. Solit, David M. Hyman, Michael F. Berger, Marc Ladanyi, Mark E. Robson, Kenneth Offit - JAMA 2017 cited by 523

  11. Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew V. Biankin, Kenneth R. Shroyer, Brian M. Wolpin, Andrew J. Aguirre, Andrea Ventura, Barry S. Taylor, Channing J. Der, Daniel Domínguez, Daniel Kümmel, Andrea Oeckinghaus, Scott W. Lowe, Robert K. Bradley, Omar Abdel‐Wahab, Steven D. Leach - Cancer Cell 2020 cited by 158

  12. A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS

    Authors: , , , , , , , , , , , , , - Cell stem cell 2023 cited by 72

  13. Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 cited by 157

  14. EIF1AX and RAS Mutations Cooperate to Drive Thyroid Tumorigenesis through ATF4 and c-MYC

    Authors: , , , , , , , , , , , , , , , , , - Cancer Discovery 2018 cited by 92

  15. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE).

    Authors: , , , , , , , , , , , , - 2001 cited by 578

  16. Transactivation from Gal4-VP16 transgenic insertions for tissue-specific cell labeling and ablation in zebrafish

    Authors: , , , , , , , , - Developmental Biology 2007 cited by 464

  17. Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions

    Authors: , , , , - Gastroenterology 2015 cited by 162

  18. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 412

  19. Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenneth Offit, Zsofia K. Stadler, Eileen M. O’Reilly - JNCI Journal of the National Cancer Institute 2018 cited by 224

  20. Notch-responsive cells initiate the secondary transition in larval zebrafish pancreas

    Authors: , , , , , , - Mechanisms of Development 2009 cited by 370

  21. Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers

    Authors: , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 190

  22. Sympathetic Innervation during Development Is Necessary for Pancreatic Islet Architecture and Functional Maturation

    Authors: , , , - Cell Reports 2013 cited by 188

  23. p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells

    Authors: , , , , , , , , , , - Oncogene 2015 cited by 157

  24. Targeting eIF4A-Dependent Translation of KRAS Signaling Molecules

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 38